Iluvatar CoreX is considering an initial public offering in Hong Kong, as investor interest in Chinese artificial intelligence chipmakers builds with Beijing discouraging local firms from using Nvidia ... ( read original story ...)
China Thematic Update: New IPOs, Healthcare Momentum From Regulatory Reprieve And Innovation, New Hydroelectric Dam
China's re-rating this year, driven by stimulus measures and policy reforms, could lead to increased global flows to the country's equity market. Click to read. ( read original story ...)
Shanghai Fosun Pharma Renews Financial Services Agreement with Fosun Finance
Co ( (HK:2196) ) has provided an update. Shanghai Fosun Pharmaceutical has renewed its Financial Services Agreement with Fosun Finance for three years starting January 2026. This agreement, which ... ( read original story ...)
China Citic Bank raises $5.4 billion in HK and Shanghai IPO
China's eighth-largest lender raised $3.67 billion from its Hong Kong IPO after pricing the 4.885 billion shares offered at HK$5.86 ($0.75) each, near the high end of its indicative range, the ... ( read original story ...)
EXCLUSIVE-Ant may raise up to $17 bln in Shanghai IPO leg as … – Nasdaq
Ant plans to sell up to 1.67 billion shares in the Shanghai float, which is set to be the biggest IPO in China, eclipsing the record set by Agricultural Bank of China's 601288.SS $10.1 billion ... ( read original story ...)
Bank of China to seek listing in Shanghai – Financial Times
The bank, which has seen its shares rise 20 per cent since its listing on the Hong Kong market last week, is believed to be aiming for a July flotation in Shanghai. The bank said its plans depend ... ( read original story ...)
China’s triple stock markets are too much of a good thing
Three’s a crowd — at least, it should be when it comes to stock markets in the same country doing the same thing. Fragmentation divides investor attention and liquidity. And when new entrants steal ... ( read original story ...)